FOLD logo

Amicus Therapeutics (FOLD) Interest expense

annual interest expense:

$49.60M-$551.00K(-1.10%)
December 31, 2024

Summary

  • As of today (June 2, 2025), FOLD annual interest expense is $49.60 million, with the most recent change of -$551.00 thousand (-1.10%) on December 31, 2024.
  • During the last 3 years, FOLD annual interest expense has risen by +$17.13 million (+52.75%).
  • FOLD annual interest expense is now -1.10% below its all-time high of $50.15 million, reached on December 31, 2023.

Performance

FOLD Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

quarterly interest expense:

$11.46M-$503.00K(-4.21%)
March 31, 2025

Summary

  • As of today (June 2, 2025), FOLD quarterly interest expense is $11.46 million, with the most recent change of -$503.00 thousand (-4.21%) on March 31, 2025.
  • Over the past year, FOLD quarterly interest expense has dropped by -$981.00 thousand (-7.89%).
  • FOLD quarterly interest expense is now -11.79% below its all-time high of $12.99 million, reached on September 30, 2023.

Performance

FOLD quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

TTM interest expense:

$48.62M-$981.00K(-1.98%)
March 31, 2025

Summary

  • As of today (June 2, 2025), FOLD TTM interest expense is $48.62 million, with the most recent change of -$981.00 thousand (-1.98%) on March 31, 2025.
  • Over the past year, FOLD TTM interest expense has dropped by -$2.12 million (-4.19%).
  • FOLD TTM interest expense is now -4.22% below its all-time high of $50.76 million, reached on June 30, 2024.

Performance

FOLD TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

FOLD Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.1%-7.9%-4.2%
3 y3 years+52.8%+40.6%+49.0%
5 y5 years+162.8%+207.2%+201.1%

FOLD Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.1%+52.8%-11.8%+40.6%-4.2%+49.0%
5 y5-year-1.1%+162.8%-11.8%+215.1%-4.2%+220.8%
alltimeall time-1.1%>+9999.0%-11.8%>+9999.0%-4.2%>+9999.0%

FOLD Interest expense History

DateAnnualQuarterlyTTM
Mar 2025
-
$11.46M(-4.2%)
$48.62M(-2.0%)
Dec 2024
$49.60M(-1.1%)
$11.96M(-5.8%)
$49.60M(-1.7%)
Sep 2024
-
$12.69M(+1.4%)
$50.47M(-0.6%)
Jun 2024
-
$12.51M(+0.6%)
$50.76M(+0.0%)
Mar 2024
-
$12.44M(-3.0%)
$50.74M(+1.2%)
Dec 2023
$50.15M(+35.1%)
$12.83M(-1.2%)
$50.15M(+3.6%)
Sep 2023
-
$12.99M(+4.0%)
$48.42M(+7.5%)
Jun 2023
-
$12.49M(+5.5%)
$45.05M(+10.4%)
Mar 2023
-
$11.84M(+6.8%)
$40.82M(+10.0%)
Dec 2022
$37.12M(+14.3%)
$11.10M(+15.3%)
$37.12M(+8.6%)
Sep 2022
-
$9.62M(+16.5%)
$34.19M(+4.4%)
Jun 2022
-
$8.26M(+1.4%)
$32.73M(+0.3%)
Mar 2022
-
$8.15M(-0.2%)
$32.63M(+0.5%)
Dec 2021
$32.47M(+44.8%)
$8.16M(-0.0%)
$32.47M(-0.3%)
Sep 2021
-
$8.16M(+0.2%)
$32.58M(+4.4%)
Jun 2021
-
$8.15M(+2.0%)
$31.20M(+16.9%)
Mar 2021
-
$7.99M(-3.4%)
$26.69M(+19.0%)
Dec 2020
$22.43M(+18.8%)
$8.28M(+22.0%)
$22.43M(+25.2%)
Sep 2020
-
$6.78M(+86.6%)
$17.91M(+18.2%)
Jun 2020
-
$3.63M(-2.5%)
$15.16M(-6.1%)
Mar 2020
-
$3.73M(-1.0%)
$16.15M(-14.4%)
Dec 2019
$18.87M(-15.8%)
$3.77M(-6.4%)
$18.87M(-20.5%)
Sep 2019
-
$4.03M(-13.0%)
$23.74M(-2.8%)
Jun 2019
-
$4.63M(-28.3%)
$24.43M(+0.3%)
Mar 2019
-
$6.45M(-25.3%)
$24.37M(+8.8%)
Dec 2018
$22.40M(+29.9%)
$8.64M(+83.2%)
$22.40M(+23.2%)
Sep 2018
-
$4.71M(+3.4%)
$18.18M(+2.0%)
Jun 2018
-
$4.56M(+1.6%)
$17.82M(+2.2%)
Mar 2018
-
$4.49M(+1.5%)
$17.44M(+1.1%)
Dec 2017
$17.24M(+219.4%)
$4.42M(+1.6%)
$17.24M(+17.3%)
Sep 2017
-
$4.35M(+4.1%)
$14.70M(+23.9%)
Jun 2017
-
$4.18M(-2.6%)
$11.87M(+35.7%)
Mar 2017
-
$4.29M(+128.1%)
$8.74M(+62.0%)
DateAnnualQuarterlyTTM
Dec 2016
$5.40M(+242.1%)
$1.88M(+24.0%)
$5.40M(+23.6%)
Sep 2016
-
$1.52M(+43.8%)
$4.37M(+52.3%)
Jun 2016
-
$1.05M(+11.6%)
$2.87M(+33.3%)
Mar 2016
-
$945.00K(+11.0%)
$2.15M(+36.3%)
Dec 2015
$1.58M(+6.3%)
$851.00K(+4905.9%)
$1.58M(+42.8%)
Sep 2015
-
$17.00K(-95.0%)
$1.10M(-24.6%)
Jun 2015
-
$338.00K(-9.1%)
$1.47M(-2.4%)
Mar 2015
-
$372.00K(-1.6%)
$1.50M(+1.1%)
Dec 2014
$1.48M(+3126.1%)
$378.00K(+0.3%)
$1.48M(+31.8%)
Sep 2014
-
$377.00K(+0.8%)
$1.13M(+48.9%)
Jun 2014
-
$374.00K(+5.4%)
$756.00K(+93.4%)
Mar 2014
-
$355.00K(+1675.0%)
$391.00K(+750.0%)
Dec 2013
$46.00K(-48.3%)
$20.00K(+185.7%)
$46.00K(+21.1%)
Sep 2013
-
$7000.00(-22.2%)
$38.00K(-24.0%)
Jun 2013
-
$9000.00(-10.0%)
$50.00K(-10.7%)
Mar 2013
-
$10.00K(-16.7%)
$56.00K(-37.1%)
Dec 2012
$89.00K(-39.9%)
$12.00K(-36.8%)
$89.00K(-14.4%)
Sep 2012
-
$19.00K(+26.7%)
$104.00K(-11.1%)
Jun 2012
-
$15.00K(-65.1%)
$117.00K(-18.2%)
Mar 2012
-
$43.00K(+59.3%)
$143.00K(-3.4%)
Dec 2011
$148.00K(-43.1%)
$27.00K(-15.6%)
$148.00K(-16.9%)
Sep 2011
-
$32.00K(-22.0%)
$178.00K(-16.0%)
Jun 2011
-
$41.00K(-14.6%)
$212.00K(-6.2%)
Mar 2011
-
$48.00K(-15.8%)
$226.00K(-13.4%)
Dec 2010
$260.00K(-6.5%)
$57.00K(-13.6%)
$261.00K(-20.2%)
Sep 2010
-
$66.00K(+20.0%)
$327.00K(-5.2%)
Jun 2010
-
$55.00K(-33.7%)
$345.00K(+4.2%)
Mar 2010
-
$83.00K(-32.5%)
$331.00K(+19.5%)
Dec 2009
$278.00K(+27.5%)
$123.00K(+46.4%)
$277.00K(+79.9%)
Sep 2009
-
$84.00K(+104.9%)
$154.00K(+120.0%)
Jun 2009
-
$41.00K(+41.4%)
$70.00K(+141.4%)
Mar 2009
-
$29.00K
$29.00K
Dec 2008
$218.00K
-
-

FAQ

  • What is Amicus Therapeutics annual interest expense?
  • What is the all time high annual interest expense for Amicus Therapeutics?
  • What is Amicus Therapeutics annual interest expense year-on-year change?
  • What is Amicus Therapeutics quarterly interest expense?
  • What is the all time high quarterly interest expense for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly interest expense year-on-year change?
  • What is Amicus Therapeutics TTM interest expense?
  • What is the all time high TTM interest expense for Amicus Therapeutics?
  • What is Amicus Therapeutics TTM interest expense year-on-year change?

What is Amicus Therapeutics annual interest expense?

The current annual interest expense of FOLD is $49.60M

What is the all time high annual interest expense for Amicus Therapeutics?

Amicus Therapeutics all-time high annual interest expense is $50.15M

What is Amicus Therapeutics annual interest expense year-on-year change?

Over the past year, FOLD annual interest expense has changed by -$551.00K (-1.10%)

What is Amicus Therapeutics quarterly interest expense?

The current quarterly interest expense of FOLD is $11.46M

What is the all time high quarterly interest expense for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly interest expense is $12.99M

What is Amicus Therapeutics quarterly interest expense year-on-year change?

Over the past year, FOLD quarterly interest expense has changed by -$981.00K (-7.89%)

What is Amicus Therapeutics TTM interest expense?

The current TTM interest expense of FOLD is $48.62M

What is the all time high TTM interest expense for Amicus Therapeutics?

Amicus Therapeutics all-time high TTM interest expense is $50.76M

What is Amicus Therapeutics TTM interest expense year-on-year change?

Over the past year, FOLD TTM interest expense has changed by -$2.12M (-4.19%)
On this page